- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04549181
Problem-Solving for Rural Heart Failure Dyads
Enhancing Problem-Solving Skills in Underserved Rural Heart Failure Dyads
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The long-term goal of this research is to reduce morbidity and improve HF self-care by enhancing family problem-solving and collaborative care management among rural HF dyads. The initial step in meeting this goal is to develop and pilot-test a culturally-sensitive, telephone-based, tailored dyadic problem-solving intervention to improve HF self-care in rural HF dyads. Using a multi-phase, sequential qualitative and quantitative approach, the following research aims are to: 1) identify the major dyadic HF-related problems dyads experience and how these problems are managed; 2) develop a telephone-based, tailored dyadic problem-solving intervention and determine its feasibility and acceptability for managing HF-related problems; and 3) evaluate the preliminary effects of the telephone-based, tailored dyadic problem-solving intervention on dyadic problem-solving and patient and family caregiver contributions to HF self-care. As an exploratory aim, we will also evaluate the effectiveness of the dyadic problem-solving intervention on caregiver burden, self-care, and life changes. In Phase I, qualitative inquiry will guide in-depth semi-structured dyad interviews (n = 12-20 dyads; 24-40 participants) to identify the dyadic HF-related problems experienced by rural HF dyads and associated management strategies (Aim 1). Phase II will be guided by qualitative and quantitative methods and include a repeated measures, single-group design to evaluate the feasibility, acceptability, and preliminary effectiveness of the 12-week dyadic problem-solving intervention in a sample of rural HF dyads (n = 60 dyads; 120 participants) (Aims 2, 3). Participants for this study will be recruited from from the Florida State University Institute for Successful Longevity Participant Registry, outpatient HF/cardiac and rural healthcare clinics affiliated with Tallahassee Memorial Hospital, Bond Community Health Clinic, via social medial and newspaper ads, and publicly available community sites (e.g., senior centers, post offices, grocery stores, etc.).
Phase I (Arm 1) will identify dyadic HF-related problems and management strategies using semi-structured interviews in a sample of rural-residing HF dyads (n = 12-20 dyads; 24-40 participants). Following consent, interviews will occur once and be approximately 45 minutes long. Qualitative data from Phase I will be analyzed using thematic analytic methods and NVivo11. Information gained in Phase I will be used to develop the telephone-based, tailored, dyadic problem-solving intervention for rural HF dyads tested in Phase II.
Phase II (Arm II) will be guided by qualitative and quantitative inquiry and include a single-group, repeated measures design with time and dyad-member as within-subject factors. A sample size of 60 dyads (120 participants) is desired based on a power analysis for repeated measures ANOVA with 4 time points, alpha level of .05, a medium effect size (f = 0.25), and 80% power, plus oversampling for potential attrition (20%). Following verbal informed consent via telephone, all dyads will be screened for cognitive impairment using the Telephone Interview for Cognitive Status (TICS) prior to baseline data collection, which will include a Sociodemographic and Clinical Survey, the Self-Care of HF Index (SCHFI; v. 6.2) (patients only), the Caregiver Contribution to the Self-Care of HF Index (CCSCHFI) (caregivers only), Healthcare Utilization Survey, the Social Problem-Solving Inventory Revised-Short (SPSIRS), the Center for Epidemiological Studies-Depression (CESD), the Global Family Function Subscale (GFF) of the Family Assessment Device Questionnaire, and the Interpersonal Support Evaluation List-12 (ISEL-12). Caregivers will also complete the Dutch Objective Burden Inventory (DOBI), Denyes Self-care Practice Instrument (DENYES), and the BAKAS Caregiving Outcomes Scale (BAKAS).
Using a single group design, all dyads will participate in a problem-solving training intervention over 12 weeks (Weeks 1-4, 6, 8, 10, 12), with follow-up data collection occurring at weeks 5, 9, 11, 13. Qualitative data will be collected at weeks 5 and 11 via semi-structured interviews with dyads. Quantitative data on study outcomes and covariates will be collected at weeks 5, 9, and 13 and consist of the SCHFI (patient), CCSCHFI (caregiver), healthcare utilization (patient), SPSIRS (dyad), REALM (dyad), CESD (dyad), GFF (dyad),ISEL-12 (dyad), DOBI (caregiver), Denyes (caregiver) and the BAKAS (caregiver). All data will be self-report and collected by a trained research assistant who will collect study data over the telephone and mark participants answers on a computerized data spreadsheet. Qualitative data will be analyzed using thematic analytic methods and NVivo11. Possible treatment effectiveness on dyadic problem-solving, patient and caregiver contributions to HF self-care, healthcare utilization, caregiver burden, caregiver self-care, caregiver life changes, and differences among subgroups (gender, relationship type) over the 13 weeks will be examined using multilevel modeling and dyadic Growth Curve Modeling (GCM).
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Lucinda J Graven, PhD APRN
- Phone Number: 850-644-5601
- Email: lgraven@fsu.edu
Study Locations
-
-
Florida
-
Blountstown, Florida, United States, 32424
- Tallahassee Memorial Hospital Physician Partners - Blountstown Clinic
-
Crawfordville, Florida, United States, 32327
- Tallahassee Memorial Hospital Physician Partners - Wakulla Clinic
-
Marianna, Florida, United States, 32446
- Talllahassee Memorial Physician Partners Cardiology - Marianna Clinic
-
Monticello, Florida, United States, 32344
- Tallahassee Memorial Hospital Physician Partners - Monticello Clinic
-
Perry, Florida, United States, 32347
- Tallahassee Memorial Hospital Physician Partners - Perry Clinic
-
Quincy, Florida, United States, 32351
- Tallahassee Memorial Hospital Physician Partners - Quincy Clinic
-
Tallahassee, Florida, United States, 32301
- Bond Community Health Center
-
Tallahassee, Florida, United States, 32308
- Tallahassee Memorial Hospital Physician Partners Cardiology Heart Failure Clinic
-
Tallahassee, Florida, United States, 32324
- HCA Capital Cardiology Associates
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- ≥ 18 years of age
- consist of a patient with New York Heart Association Class II- IV HF and their family caregiver
- live in a rural area
- read, write, and communicate verbally in English
- have access to a telephone with speaker capability
- family caregivers are defined as a spouse/partner or adult family member living in the same household and/or considered to be the primary caregiver and may be healthy
Exclusion Criteria:
- patient has HF due to a correctable cause or condition
- either dyad member exhibits cognition dysfunction (i.e., score ≤ 30 on the Telephone Interview for Cognitive Status [TICS])
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Non-Randomized
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Phase I: Qualitative
Rural HF dyads will participate in a one-time telephone-based semi-structured interview to explore the types of HF-related problems that rural HF dyads experience and how these problems are managed.
|
|
Experimental: Phase II: Problem-Solving for Rural HF Dyads
The dyadic problem-solving intervention will be provided by a HF specialist nurse.
The nurse will conduct the initial telehealth (virtual, telephone) session and provide dyads with an intervention booklet containing examples of common HF-related problems experienced by rural dyads and suggested management strategies tailored to the rural sociocultural context.
The nurse will lead dyads in a card sorting task intended to help dyads prioritize current HF-related problems and will guide dyads in developing management strategies for the highest priority problem.
Dyads will utilize these strategies until the next session at which time the nurse will guide dyads in evaluating the effectiveness of chosen strategies.
The iterative process then begins again.
Dyads will receive 7 follow-up telephone sessions with the nurse.
In the intervention, the nurse will focus on problems related to self-care, including those specific to the rural population.
|
Participants in the Intervention Group will be trained to use a 4-step problem-solving process based on the Theory of Social Problem-Solving (TSPS) to manage HF-related problems collaboratively over 12-weeks.
The core belief of TSPS is effective problem-solving requires a positive problem orientation (i.e., viewing problems as a challenge versus a threat) and elicits rational problem-solving versus avoidance or impulsivity/carelessness.
Dyadic problem-solving follows from a positive problem orientation and involves accurate problem identification, generation of appropriate potential solutions, active decision-making, and solution implementation and evaluation.
The goal of this dyadic intervention is to move HF dyads toward a positive problem orientation and use of rational problem-solving strategies that support greater patient and family caregiver-contributed HF self-care.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Self-Care Maintenance (HF patient)
Time Frame: Baseline, 5 weeks
|
Self-care maintenance will be self-reported and measured using the Self-care of Heart Failure Index (SCHFI) v. 6.2.
Items pertain to treatment adherence and self-monitoring.
Scores are standardized (0-100), with higher scores suggesting better self-care maintenance.
Scores ≥ 70 are considered adequate, with an improvement of 8 or more considered clinically significant.
|
Baseline, 5 weeks
|
Self-Care Maintenance (HF patient)
Time Frame: Baseline, 9 weeks
|
Self-care maintenance will be self-reported and measured using the Self-care of Heart Failure Index (SCHFI) v. 6.2.
Items pertain to treatment adherence and self-monitoring.
Scores are standardized (0-100), with higher scores suggesting better self-care maintenance.
Scores ≥ 70 are considered adequate, with an improvement of 8 or more considered clinically significant.
|
Baseline, 9 weeks
|
Self-Care Maintenance (HF patient)
Time Frame: Baseline, 13 weeks
|
Self-care maintenance will be self-reported and measured using the Self-care of Heart Failure Index (SCHFI) v. 6.2.
Items pertain to treatment adherence and self-monitoring.
Scores are standardized (0-100), with higher scores suggesting better self-care maintenance.
Scores ≥ 70 are considered adequate, with an improvement of 8 or more considered clinically significant.
|
Baseline, 13 weeks
|
Self-Care Management (HF patient)
Time Frame: Baseline, 5 weeks
|
Self-care management will be self-reported and measured using the Self-care of Heart Failure Index (SCHFI) v. 6.2.
Items pertain to symptom recognition and treatment and evaluation of treatment effectiveness.
Scores are standardized (0-100), with higher scores suggesting better self-care management.
Scores ≥ 70 are considered adequate, with an improvement of 8 or more considered clinically significant.
|
Baseline, 5 weeks
|
Self-Care Management (HF patient)
Time Frame: Baseline, 9 weeks
|
Self-care management will be self-reported and measured using the Self-care of Heart Failure Index (SCHFI) v. 6.2.
Items pertain to symptom recognition and treatment and evaluation of treatment effectiveness.
Scores are standardized (0-100), with higher scores suggesting better self-care management.
Scores ≥ 70 are considered adequate, with an improvement of 8 or more considered clinically significant.
|
Baseline, 9 weeks
|
Self-Care Management (HF patient)
Time Frame: Baseline, 13 weeks
|
Self-care management will be self-reported and measured using the Self-care of Heart Failure Index (SCHFI) v. 6.2.
Items pertain to symptom recognition and treatment and evaluation of treatment effectiveness.
Scores are standardized (0-100), with higher scores suggesting better self-care management.
Scores ≥ 70 are considered adequate, with an improvement of 8 or more considered clinically significant.
|
Baseline, 13 weeks
|
Self-Care Confidence (HF patient)
Time Frame: Baseline, 5 weeks
|
Self-care confidence will be self-reported and measured using the Self-care of Heart Failure Index (SCHFI) v. 6.2.
Items pertain to one's confidence in their ability to perform self-care activities.
Scores are standardized (0-100), with higher scores suggesting better self-care confidence.
Scores ≥ 70 are considered adequate, with an improvement of 8 or more considered clinically significant.
|
Baseline, 5 weeks
|
Self-Care Confidence (HF patient)
Time Frame: Baseline, 9 weeks
|
Self-care confidence will be self-reported and measured using the Self-care of Heart Failure Index (SCHFI) v. 6.2.
Items pertain to one's confidence in their ability to perform self-care activities.
Scores are standardized (0-100), with higher scores suggesting better self-care confidence.
Scores ≥ 70 are considered adequate, with an improvement of 8 or more considered clinically significant.
|
Baseline, 9 weeks
|
Self-Care Confidence (HF patient)
Time Frame: Baseline, 13 weeks
|
Self-care confidence will be self-reported and measured using the Self-care of Heart Failure Index (SCHFI) v. 6.2.
Items pertain to one's confidence in their ability to perform self-care activities.
Scores are standardized (0-100), with higher scores suggesting better self-care confidence.
Scores ≥ 70 are considered adequate, with an improvement of 8 or more considered clinically significant.
|
Baseline, 13 weeks
|
Caregiver Contribution to Self-Care Maintenance (caregiver)
Time Frame: Baseline, 5 weeks
|
Caregiver contribution to self-care maintenance will be self-reported and measured using the Caregiver Contribution to Self-care of Heart Failure Index (SCHFI).
Items pertain to one's contribution to treatment adherence and symptom monitoring.
Scores are standardized (0-100), with higher scores suggesting higher contribution to self-care maintenance.
|
Baseline, 5 weeks
|
Caregiver Contribution to Self-Care Maintenance (caregiver)
Time Frame: Baseline, 9 weeks
|
Caregiver contribution to self-care maintenance will be self-reported and measured using the Caregiver Contribution to Self-care of Heart Failure Index (SCHFI).
Items pertain to one's contribution to treatment adherence and symptom monitoring.
Scores are standardized (0-100), with higher scores suggesting higher contribution to self-care maintenance.
|
Baseline, 9 weeks
|
Caregiver Contribution to Self-Care Maintenance (caregiver)
Time Frame: Baseline, 13 weeks
|
Caregiver contribution to self-care maintenance will be self-reported and measured using the Caregiver Contribution to Self-care of Heart Failure Index (SCHFI).
Items pertain to one's contribution to treatment adherence and symptom monitoring.
Scores are standardized (0-100), with higher scores suggesting higher contribution to self-care maintenance.
|
Baseline, 13 weeks
|
Caregiver Contribution to Self-Care Management (caregiver)
Time Frame: Baseline, 5 weeks
|
Caregiver contribution to self-care management will be self-reported and measured using the Caregiver Contribution to Self-care of Heart Failure Index (SCHFI).
Items pertain to one's contribution to symptom recognition and treatment and evaluation of treatment effectiveness.
Scores are standardized (0-100), with higher scores suggesting higher contribution to self-care management.
|
Baseline, 5 weeks
|
Caregiver Contribution to Self-Care Management (caregiver)
Time Frame: Baseline, 9 weeks
|
Caregiver contribution to self-care management will be self-reported and measured using the Caregiver Contribution to Self-care of Heart Failure Index (SCHFI).
Items pertain to one's contribution to symptom recognition and treatment and evaluation of treatment effectiveness.
Scores are standardized (0-100), with higher scores suggesting higher contribution to self-care management.
|
Baseline, 9 weeks
|
Caregiver Contribution to Self-Care Management (caregiver)
Time Frame: Baseline, 13 weeks
|
Caregiver contribution to self-care management will be self-reported and measured using the Caregiver Contribution to Self-care of Heart Failure Index (SCHFI).
Items pertain to one's contribution to symptom recognition and treatment and evaluation of treatment effectiveness.
Scores are standardized (0-100), with higher scores suggesting higher contribution to self-care management.
|
Baseline, 13 weeks
|
Caregiver Contribution to Self-Care Confidence (caregiver)
Time Frame: Baseline, 5 weeks
|
Caregiver contribution to self-care confidence will be self-reported and measured using the Caregiver Contribution to Self-care of Heart Failure Index (SCHFI).
Items pertain to one's contribution to confidence in self-care ability.
Scores are standardized (0-100), with higher scores suggesting higher contribution to self-care confidence.
|
Baseline, 5 weeks
|
Caregiver Contribution to Self-Care Confidence (caregiver)
Time Frame: Baseline, 9 weeks
|
Caregiver contribution to self-care confidence will be self-reported and measured using the Caregiver Contribution to Self-care of Heart Failure Index (SCHFI).
Items pertain to one's contribution to confidence in self-care ability.
Scores are standardized (0-100), with higher scores suggesting higher contribution to self-care confidence.
|
Baseline, 9 weeks
|
Caregiver Contribution to Self-Care Confidence (caregiver)
Time Frame: Baseline, 13 weeks
|
Caregiver contribution to self-care confidence will be self-reported and measured using the Caregiver Contribution to Self-care of Heart Failure Index (SCHFI).
Items pertain to one's contribution to confidence in self-care ability.
Scores are standardized (0-100), with higher scores suggesting higher contribution to self-care confidence.
|
Baseline, 13 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Healthcare Utilization (patient)
Time Frame: baseline, 5 weeks
|
Healthcare utilization will be determined by the frequency of emergency department visits and 30-day readmissions for HF and assessed via self-report.
|
baseline, 5 weeks
|
Healthcare Utilization (patient)
Time Frame: baseline, 9 weeks
|
Healthcare utilization will be determined by the frequency of emergency department visits and 30-day readmissions for HF and assessed via self-report.
|
baseline, 9 weeks
|
Healthcare Utilization (patient)
Time Frame: baseline, 13 weeks
|
Healthcare utilization will be determined by the frequency of emergency department visits and 30-day readmissions for HF and assessed via self-report.
|
baseline, 13 weeks
|
Problem-Solving (HF patient and caregiver)
Time Frame: baseline, 5 weeks
|
Problem-solving will be self-reported and assessed using the Social Problem-Solving Inventory Revised (SPSIR) which measures problem orientation and problem-solving style.
In addition to a total score, there are 5 sub-scales: positive problem orientation, negative problem orientation, rational problem-solving, impulsivity/carelessness, and avoidance style.
Higher scores on each sub-scale suggest more of the problem-solving characteristic.
Higher total scores suggest more adaptive problem-solving, while lower scores indicate more maladaptive problem-solving.
|
baseline, 5 weeks
|
Problem-Solving (HF patient and caregiver)
Time Frame: baseline, 9 weeks
|
Problem-solving will be self-reported and assessed using the Social Problem-Solving Inventory Revised (SPSIR) which measures problem orientation and problem-solving style.
In addition to a total score, there are 5 sub-scales: positive problem orientation, negative problem orientation, rational problem-solving, impulsivity/carelessness, and avoidance style.
Higher scores on each sub-scale suggest more of the problem-solving characteristic.
Higher total scores suggest more adaptive problem-solving, while lower scores indicate more maladaptive problem-solving.
|
baseline, 9 weeks
|
Problem-Solving (HF patient and caregiver)
Time Frame: baseline,13 weeks
|
Problem-solving will be self-reported and assessed using the Social Problem-Solving Inventory Revised (SPSIR) which measures problem orientation and problem-solving style.
In addition to a total score, there are 5 sub-scales: positive problem orientation, negative problem orientation, rational problem-solving, impulsivity/carelessness, and avoidance style.
Higher scores on each sub-scale suggest more of the problem-solving characteristic.
Higher total scores suggest more adaptive problem-solving, while lower scores indicate more maladaptive problem-solving.
|
baseline,13 weeks
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Depression (patient and caregiver)
Time Frame: baseline, 5 weeks
|
Depression will be self-reported and assessed using the 20-item Center for Epidemiological Studies-Depression Scale (CES-D).
The CES-D measures the presence of depression.
Scores range from 0-60, with higher scores indicative of more symptoms of depression.
A cut-off score ≥ 16 indicates depressed versus non-depressed.
|
baseline, 5 weeks
|
Depression (patient and caregiver)
Time Frame: baseline, 9 weeks
|
Depression will be self-reported and assessed using the 20-item Center for Epidemiological Studies-Depression Scale (CES-D).
The CES-D measures the presence of depression.
Scores range from 0-60, with higher scores indicative of more symptoms of depression.
A cut-off score ≥ 16 indicates depressed versus non-depressed.
|
baseline, 9 weeks
|
Depression (patient and caregiver)
Time Frame: baseline, 13 weeks
|
Depression will be self-reported and assessed using the 20-item Center for Epidemiological Studies-Depression Scale (CES-D).
The CES-D measures the presence of depression.
Scores range from 0-60, with higher scores indicative of more symptoms of depression.
A cut-off score ≥ 16 indicates depressed versus non-depressed.
|
baseline, 13 weeks
|
Family Function (patient and caregiver)
Time Frame: baseline, 5 weeks
|
Family function will be self-reported and measured using the Global Family Function (GFF) Subscale of the Family Assessment Device Questionnaire (12-items.The GFF assesses perception of overall family health related to problem-solving, communication, roles, active responses, affective involvement, and behavior control.
Final mean scores range from 1 to 4 (healthy to unhealthy family functioning).
|
baseline, 5 weeks
|
Family Function (patient and caregiver)
Time Frame: baseline, 9 weeks
|
Family function will be self-reported and measured using the Global Family Function (GFF) Subscale of the Family Assessment Device Questionnaire (12-items.The GFF assesses perception of overall family health related to problem-solving, communication, roles, active responses, affective involvement, and behavior control.
Final mean scores range from 1 to 4 (healthy to unhealthy family functioning).
|
baseline, 9 weeks
|
Family Function (patient and caregiver)
Time Frame: baseline, 13 weeks
|
Family function will be self-reported and measured using the Global Family Function (GFF) Subscale of the Family Assessment Device Questionnaire (12-items.The GFF assesses perception of overall family health related to problem-solving, communication, roles, active responses, affective involvement, and behavior control.
Final mean scores range from 1 to 4 (healthy to unhealthy family functioning).
|
baseline, 13 weeks
|
Social Support (patient and caregiver)
Time Frame: baseline, 5 weeks
|
Social support will be self-reported and assessed using the Interpersonal Support and Evaluation List - 12 (ISEL-12) which measures perceived belonging, tangible, and appraisal support.
Scores range from 0-36, with higher scores suggesting a higher perception of available support.
|
baseline, 5 weeks
|
Social Support (patient and caregiver)
Time Frame: baseline, 9 weeks
|
Social support will be self-reported and assessed using the Interpersonal Support and Evaluation List - 12 (ISEL-12) which measures perceived belonging, tangible, and appraisal support.
Scores range from 0-36, with higher scores suggesting a higher perception of available support.
|
baseline, 9 weeks
|
Social Support (patient and caregiver)
Time Frame: baseline, 13 weeks
|
Social support will be self-reported and assessed using the Interpersonal Support and Evaluation List - 12 (ISEL-12) which measures perceived belonging, tangible, and appraisal support.
Scores range from 0-36, with higher scores suggesting a higher perception of available support.
|
baseline, 13 weeks
|
Caregiver Burden (caregiver)
Time Frame: baseline, 5 weeks
|
Caregiver burden will be self-reported and assessed using the Dutch Objective Burden Inventory (DOBI), which measures both objective and subjective burden.
Responses for each item range from 1 (no, never, not at all burdensome) to 3 (yes, often or always, very burdensome), with total scores on each subscale ranging from 1-3.
Higher scores indicate greater perceived objective and subjective burden.
|
baseline, 5 weeks
|
Caregiver Burden (caregiver)
Time Frame: baseline, 9 weeks
|
Caregiver burden will be self-reported and assessed using the Dutch Objective Burden Inventory (DOBI), which measures both objective and subjective burden.
Responses for each item range from 1 (no, never, not at all burdensome) to 3 (yes, often or always, very burdensome), with total scores on each subscale ranging from 1-3.
Higher scores indicate greater perceived objective and subjective burden.
|
baseline, 9 weeks
|
Caregiver Burden (caregiver)
Time Frame: baseline, 13 weeks
|
Caregiver burden will be self-reported and assessed using the Dutch Objective Burden Inventory (DOBI), which measures both objective and subjective burden.
Responses for each item range from 1 (no, never, not at all burdensome) to 3 (yes, often or always, very burdensome), with total scores on each subscale ranging from 1-3.
Higher scores indicate greater perceived objective and subjective burden.
|
baseline, 13 weeks
|
Caregiver Self-care (caregiver)
Time Frame: baseline, 5 weeks
|
Caregiver self-care will be measured using the 18-item Denyes Self-care Practice Instrument (DENYES) which measures self-care activities that are universal self-care requisites (e.g., diet, rest, exercise, etc.).
Response options for each item range from 0 to 156, with a total score calculated by averaging the time responses for all behaviors, with higher scores representing better self-care.
|
baseline, 5 weeks
|
Caregiver Self-care (caregiver)
Time Frame: baseline, 9 weeks
|
Caregiver self-care will be measured using the 18-item Denyes Self-care Practice Instrument (DENYES) which measures self-care activities that are universal self-care requisites (e.g., diet, rest, exercise, etc.).
Response options for each item range from 0 to 156, with a total score calculated by averaging the time responses for all behaviors, with higher scores representing better self-care.
|
baseline, 9 weeks
|
Caregiver Self-care (caregiver)
Time Frame: baseline, 13 weeks
|
Caregiver self-care will be measured using the 18-item Denyes Self-care Practice Instrument (DENYES) which measures self-care activities that are universal self-care requisites (e.g., diet, rest, exercise, etc.).
Response options for each item range from 0 to 156, with a total score calculated by averaging the time responses for all behaviors, with higher scores representing better self-care.
|
baseline, 13 weeks
|
Life Changes (caregiver)
Time Frame: baseline, 5 weeks
|
Caregiving-related life changes will be measured using the 15-item Bakas Caregiving Outcomes Scale.
This instrument measures care partners' perceptions of how caregiving has influenced their social functioning, subjective well-being, and physical health using a 7-point (-3 [1] to +3 [7]) Likert-type scale.
Total scores range from 15 to 105, with higher scores indicating more positive caregiving-related life changes.
|
baseline, 5 weeks
|
Life Changes (caregiver)
Time Frame: baseline, 9 weeks
|
Caregiving-related life changes will be measured using the 15-item Bakas Caregiving Outcomes Scale.
This instrument measures care partners' perceptions of how caregiving has influenced their social functioning, subjective well-being, and physical health using a 7-point (-3 [1] to +3 [7]) Likert-type scale.
Total scores range from 15 to 105, with higher scores indicating more positive caregiving-related life changes.
|
baseline, 9 weeks
|
Life Changes (caregiver)
Time Frame: baseline, 13 weeks
|
Caregiving-related life changes will be measured using the 15-item Bakas Caregiving Outcomes Scale.
This instrument measures care partners' perceptions of how caregiving has influenced their social functioning, subjective well-being, and physical health using a 7-point (-3 [1] to +3 [7]) Likert-type scale.
Total scores range from 15 to 105, with higher scores indicating more positive caregiving-related life changes.
|
baseline, 13 weeks
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 00001621
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Heart Failure
-
Tufts Medical CenterMetro West Medical CenterCompletedCongestive Heart Failure | Diastolic Heart Failure | Systolic Heart FailureUnited States
-
Abbott Medical DevicesCompletedHeart Failure | Heart Failure, Diastolic | Heart Failure, Systolic | Heart Failure NYHA Class II | Heart Failure NYHA Class III | Heart Failure With Reduced Ejection Fraction | Heart Failure NYHA Class IV | Heart Failure With Normal Ejection Fraction | Heart Failure; With Decompensation | Heart Failure...United States, Canada
-
Manipal UniversityUnknownHeart Failure | Decompensated Heart Failure | Acute Heart Failure | Diastolic Heart Failure | Systolic Heart FailureIndia
-
VA Eastern Colorado Health Care SystemNational Institute on Aging (NIA)CompletedHeart Failure | Heart Failure, Diastolic | Heart Failure, Systolic | Heart Failure With Reduced Ejection Fraction | Heart Failure With Preserved Ejection Fraction | Heart Failure; With Decompensation | Heart Failure,Congestive | Heart Failure AcuteUnited States
-
University Hospital, MontpellierCompletedHeart Failure | Diastolic Heart Failure | Systolic Heart Failure Stage CFrance
-
Lancaster General HospitalLouise von Hess Medical Research InstituteEnrolling by invitationDiastolic Heart FailureUnited States
-
Wake Forest UniversityCompletedHeart Failure, Congestive | Heart Failure With Preserved Ejection Fraction
-
Wake Forest UniversityNational Institute on Aging (NIA)CompletedHeart Failure, Congestive | Diastolic Heart FailureUnited States
-
US Department of Veterans AffairsCompleted
-
Giresun UniversityIstanbul University - Cerrahpasa (IUC)RecruitingHeart Failure | Diastolic Heart Failure | Systolic Heart FailureTurkey